fbpx

All Memorial Sloan Kettering Cancer Center

  • Ola C. Landgren, MD, PHD

    Position: Chief, Myeloma Service Research Focus:Dr. Landgren is a board-certified hematologist-oncologist whose research focuses on the development of novel treatment strategies and advanced disease monitoring by new minimal residual disease (MRD) assays, as well as biological studies focusing on disease and host biology. He also studies mechanism and markers of Read more [...]

  • Sergio Giralt, MD

    Position: Chief, Adult Bone Marrow Transplant Service; Melvin Berlin Family Chair in Multiple Myeloma. Research Focus: Dr. Sergio Giralt’s research focus is on stem cell transplantation for patients with blood disorders. He specializes in conditioning regimens for older or more debilitated patients with blood cancers. Before this discovery, older patients Read more [...]

  • Alex Lesokhin, MD

    Position: Board-certified hematologist/oncologist specializing in multiple myeloma. Research Focus: A broad range of clinical trials are available at our center for patients with newly diagnosed myeloma, relapsed myeloma, and also transplant trials. Dr. Lesokhin has a specific interest in using immune based treatment strategies for myeloma treatment. Additional Resources: Anti-PD-1 Read more [...]

  • Heather Landau, MD

    Position: Board-certified oncologist and hematologist specializing in multiple myeloma and light chain amyloidosis. Research Focus:Dr. Heather Landau’s research focuses on new treatment approaches for plasma cell disorders. Along with colleagues here, she is testing targeted therapies, immunomodulatory agents, and stem cell transplantation to arrive at more-effective and less-toxic regimens for Read more [...]

  • Hani Hassoun, MD

    Position: Board-certified hematologist/oncologist specializing in multiple myeloma Research Focus: I am a board-certified hematologist/oncologist with a special interest in plasma cell dyscrasias — a group of disorders that includes multiple myeloma, amyloidosis, light chain deposition disease, POEMS syndrome, and Waldenström’s macroglobulinemia. There have been tremendous advances in this field over Read more [...]

  • Nikoletta Lendvai, MD, PHD

    Position: Hematologist Research Focus: I am a hematologist with a special interest in the treatment of multiple myeloma and immunotherapy. My clinical research focuses on combining current treatments for myeloma (including those now in clinical trials) with immunotherapy. This makes sense because our current treatments and those treatments that are Read more [...]

  • David Chung, MD, PHD

    Position: Dr. Chung is a medical oncologist with expertise treating adult patients undergoing stem cell transplantation for hematologic malignancies. Dr. Chung is part of the Department of Defense, Experimental Therapeutics Center (MSKCC) and the Society of Memorial Sloan Kettering Cancer Center. Research Focus: Dr. David Chung’s research focus is on Read more [...]

  • Sham Mailankody, MBBS

    Position:Board-certified hematologist/oncologist specializing in multiple myeloma Research Focus: I am a medical oncologist and hematologist specializing in the care of people with multiple myeloma and related plasma cell disorders. With my colleagues at Memorial Sloan Kettering Cancer Center, I am focused on identifying optimal treatment strategies for people with these Read more [...]

  • Neha Korde, MD

    Position: Hematologist Research Focus: I am a board-certified hematologist specializing in the treatment of multiple myeloma and other plasma cell neoplasms. I have a particular research interest in early plasma cell disorders, including monoclonal gammopathy of unknown significance (MGUS) and smoldering myeloma (SMM), and understanding disease biology that may promote Read more [...]